Market news

Cooke & Bieler, an investment management firm, released its second-quarter investor letter for “Mid Cap Value Equity Strategy.” The letter can be downloaded here. U.S. equities rallied significantly in Q2, driven by shifting geopolitical risks and strong investor appetite for high-beta stocks, particularly in the tech sector, contributing to the S&P 500® and Nasdaq’s best […]

Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.

Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.

Riverwater Partners, an investment management company, released its ‘Sustainable Value Strategy’ Q2 2026 investor letter. The letter can be downloaded here. Small-cap stocks achieved their best first-half performance since 1991, with the Russell 2500 Value Index rising 17%, driven by the technology sector. The Sustainable Value Strategy underperformed its benchmark in the second quarter. The shortfall […]

Tipranks Press Release.

Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.

Detailed price information for Zymeworks Inc (ZYME-Q) from The Globe and Mail including charting and trades.

Shares of Charles River blew out of a buy zone Wednesday after hitting its highest book-to-bill ratio in four years.

Detailed price information for Humana Inc (HUM-N) from The Globe and Mail including charting and trades.

Detailed price information for Privia Health Group Inc (PRVA-Q) from The Globe and Mail including charting and trades.